Biomarkers of thrombocyte activation as predictive factor for hemorrhagic complications of strokes occurring under platelet aggregation inhibitio

Recruiting

• Conditions: I63; I61; Intracerebral haemorrhage; Cerebral infarction

• Registration Number: DRKS00030574
• Lead Sponsor: Klinik für Neurologie, Universitätsklinikum Frankfurt, Goethe Universität

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-19
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Clincal and/or radiological diagnosis of an acute ischemic or hemorrhagic stroke
- Time from symptom onset or last seen well to hospital admission <24h
- Prior antithrombotic medication (aspirin, clopidogrel, ticagrelor, prasugrel, dipyridamol) or lack thereof (control group)

Exclusion Criteria

- Prior oral anticoagulation (marcumar, dabigatran, apixaban, rivaroxaban, edoxaban) or heparin
- Administration of intravenous thromboylsis prior to blood test
- History of coagulation disorders (e.g. von Willebrand disease, Glanzmann`s thrombasthenia, Bernard-Soulier syndrome)

Study & Design

• Study Type: observational
• Study Design: Not specified